Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION

v3.20.2
SEGMENT INFORMATION
6 Months Ended
Jun. 30, 2020
NOTE 17. SEGMENT INFORMATION

NOTE 17 - SEGMENT INFORMATION

 

During 2018, the Company acquired additional real property and determined that a previously insignificant operating segment “Real Estate and Construction” was significant and was a reportable segment requiring disclosure in accordance with ASC 280. As of June 30, 2020, the majority of our real property is included in discontinued operations. As of June 30, 2020, the “Real Estate and Construction” has been merged with our “Corporate & Other” reportable segment.

 

During the six months ended June 30, 2020, the “Herbs and Produce Products” segment was discontinued as was included in discontinued operations. Prior period information below has been revised to conform to current period presentation.

 

We are now organized into two reportable segments:

 

 

Cannabis Dispensary, Cultivation and Production - Includes cannabis-focused retail, cultivation and production operations; and

 

 

 

Corporate / CBD - Includes CBD formulation and production, building ownership and corporate support operations.

   

 

 

As of and For the Three Months Ended June 30, 2020

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 3,007

 

 

$ 301

 

 

$ 3,308

 

Cost of Goods Sold

 

 

1,759

 

 

 

157

 

 

 

1,916

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

1,248

 

 

 

144

 

 

 

1,392

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

3,606

 

 

 

3,770

 

 

 

7,377

 

Impairment of Assets

 

 

4,998

 

 

 

6,316

 

 

 

11,314

 

(Gain) / Loss on Sale of Assets

 

 

-

 

 

 

-

 

 

 

-

 

(Gain) / Loss on Interest in Joint Venture

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(7,356 )

 

 

(9,943 )

 

 

(17,299 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(243 )

 

 

(599 )

 

 

(842 )

Other Income / (Loss)

 

 

(89 )

 

 

1

 

 

 

(88 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(332 )

 

 

(598 )

 

 

(930 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (7,688 )

 

$ (10,541 )

 

$ (18,229 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2020

 

$ 69,684

 

 

$ 20,862

 

 

$ 90,546

 

      

 

 

As of and For the Six Months Ended June 30, 2020

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 6,753

 

 

$ 868

 

 

$ 7,621

 

Cost of Goods Sold

 

 

3,181

 

 

 

710

 

 

 

3,891

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

3,572

 

 

 

158

 

 

 

3,730

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

7,484

 

 

 

8,929

 

 

 

16,414

 

Impairment of Assets

 

 

10,118

 

 

 

6,316

 

 

 

16,434

 

(Gain) / Loss on Sale of Assets

 

 

(35 )

 

 

-

 

 

 

(35 )

(Gain) / Loss on Interest in Joint Venture

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(13,995 )

 

 

(15,087 )

 

 

(29,082 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(488 )

 

 

(1,256 )

 

 

(1,744 )

Other Income / (Loss)

 

 

(51 )

 

 

28

 

 

 

(23 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(539 )

 

 

(1,228 )

 

 

(1,767 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (14,534 )

 

$ (16,315 )

 

$ (30,849 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2020

 

$ 69,684

 

 

$ 20,862

 

 

$ 90,546

 

 

 

As of and For the Three Months Ended June 30, 2019

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 4,477

 

 

$ -

 

 

$ 4,477

 

Cost of Goods Sold

 

 

2,177

 

 

 

-

 

 

 

2,177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

2,300

 

 

 

-

 

 

 

2,300

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

3,402

 

 

 

5,211

 

 

 

8,613

 

Impairment of Assets

 

 

114

 

 

 

396

 

 

 

510

 

(Gain) / Loss on Sale of Assets

 

 

-

 

 

 

-

 

 

 

-

 

(Gain) / Loss on Interest in Joint Venture

 

 

(0 )

 

 

-

 

 

 

(0 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(1,215 )

 

 

(5,607 )

 

 

(6,822 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(305 )

 

 

(3,314 )

 

 

(3,620 )

Other Income / (Loss)

 

 

(12 )

 

 

997

 

 

 

985

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(318 )

 

 

(2,318 )

 

 

(2,635 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (1,533 )

 

$ (7,924 )

 

$ (9,457 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2019

 

$ 92,974

 

 

$ 9,941

 

 

$ 102,916

 

  

 

 

As of and For the Six Months Ended June 30, 2019

(Unaudited)

(in thousands)

 

 

 

Cannabis

 

 

Corporate / CBD

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$ 6,522

 

 

$ -

 

 

$ 6,522

 

Cost of Goods Sold

 

 

2,622

 

 

 

-

 

 

 

2,622

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

3,900

 

 

 

-

 

 

 

3,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

6,454

 

 

 

10,750

 

 

 

17,204

 

Impairment of Assets

 

 

114

 

 

 

396

 

 

 

510

 

(Gain) / Loss on Sale of Assets

 

 

-

 

 

 

-

 

 

 

-

 

(Gain) / Loss on Interest in Joint Venture

 

 

1,067

 

 

 

-

 

 

 

1,067

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(3,734 )

 

 

(11,146 )

 

 

(14,880 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income (Expense)

 

 

(532 )

 

 

(6,015 )

 

 

(6,548 )

Other Income / (Loss)

 

 

(12 )

 

 

1,009

 

 

 

997

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expense)

 

 

(545 )

 

 

(5,007 )

 

 

(5,551 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) from continuing operations

 

$ (4,279 )

 

$ (16,152 )

 

$ (20,431 )

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets at June 30, 2019

 

$ 92,974

 

 

$ 9,941

 

 

$ 102,916